Asston Pharma Closes Trading Window for Insider Trading

Asston Pharmaceuticals Ltd has announced the closure of its trading window for all designated persons, including directors, KMPs, and their immediate relatives. This closure is in compliance with the company's Code of Conduct and SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain shut from October 1st, 2026, until 48 hours after the declaration of the unaudited financial results for the half-year ended September 30th, 2026. This measure is to prevent potential insider trading activities during the period leading up to and immediately following the financial results announcement. The date for the board meeting to approve these results will be communicated separately.